Young J. Lee, MD

Dr. Young Lee received her medical degree from Federal University of Rio Grande do Sul Medical School, Porto Alegre, Brazil in 1987, and completed her internship and residency in Internal Medicine at Jackson Memorial Hospital University of Miami, Florida. She continued on to complete fellowship in Hematology and Oncology at Jackson Memorial Hospital University of Miami.

Before joining in COHA in 2001, she was serving as an assistant professor of Medicine of Sylvester Comprehensive Cancer Center, a director of Jackson Memorial Hospital Breast Health Center, University of Miami, and an assistant professor of Medicine Greenebaum Cancer Center, University of Maryland, Baltimore, MD. She previously served as a medical director for the Breast and Cervical Cancer Program at Harbor Hospital. She served as a chief of Oncology Harbor Hospital Baltimore, Maryland between 2003 and 2014.

She is board certified in Hematology and Oncology and her clinical interests are all types of blood diseases and cancers, with special interest in breast cancer treatment and research. She is a member of the American Society of Clinical Oncology.

She sees patients in three offices, at the Tate Cancer Center, Columbia Cancer Center and Annapolis Cancer Center and speaks English, Korean, Spanish and Portuguese.

Dr. Lee’s father, an acupuncturist and Chinese herbalist, inspired her to study Medicine early in her life. After many years of training and practice in modern Hematology and Oncology, she completed The Acupunture Course for Physicians at the Harvard Medical School in 2012. She strives to treat every patient holistically, integrating alternative medicine with the state-of-the-art Western Medicine to restore the health and well-being of cancer patients.

She also has special interests and expertise in breast and gynecologic cancers and has been a pioneer in using scalp cooling caps for prevention of hair loss during chemotherapy. She is the co-founder of, a non-profit organization created to provide financial assistance for breast cancer patients who cannot afford the hair saving technology.